Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
182
NCT02223598
A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 25, 2014
Completion: Jul 26, 2017
NCT02243917
A Phase 1 Study Evaluating CB-5083 in Subjects With Advanced Solid Tumors
Start: Oct 11, 2014
Completion: Aug 25, 2017